Desk›Healthcare› Dr Lalchandani Labs Ltd
Dr Lalchandani Labs Ltd
BSE 541299 · NSE DLCL · ISIN INE871Z01013 · Group M · Active
Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider
₹7.67
+2.40%
BSE close, 28 August 2026
₹6.62 cr
0.9 cr shares · Micro cap
₹3.42 cr
as published
109.6× · —
EPS ₹0.07 · BV —
4.19 / 0.06
₹ cr, as filed
2
0 selected · 0%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -63.8% |
|---|---|
| Against 52-week low | +28.5% |
| Day change | +2.40% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹0.07 |
|---|---|
| Price / earnings | 109.57× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | — |
| Net margin | — |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Mar-26 · Q | 2.14 | -0.13 | -0.15 | 6.23% | -6.18% |
| Sep-25 · Q | 2.05 | 0.20 | 0.45 | 26.86% | 9.51% |
| FY25-26 | 4.19 | 0.06 | 0.07 | 16.34% | 1.53% |
Quarter on quarter
- Revenue, quarter on quarter
- +4.4%
- Net profit, quarter on quarter
- -165.0%
- Operating margin, quarter on quarter
- -2,063 bps
Disclosure profile 2 filings in the window
| Tag | Filings |
|---|---|
| Procedural | |
| General | 1 |
| Trading Window | 1 |
| Procedural sub-total | 2 |
| Total | 2 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group M, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
2 filings · 0 selected · busiest 2026-09-17 and 2026-09-30
Filing rhythm · the twelve most recent
2026-09-172026-09-30
SelectedProcedural
Filings
2 in the window · 3 earlier on record
-
30 September 2026 ·
Closure of Trading Window
Trading Window Closure
Insider Trading / SAST / Closure of Trading Window View filing →
-
17 September 2026 ·
Extension For Annual General Meeting For FY 2025-2026
The company due to ill health of the Chairman of the Company had filed the Application for extension of Annual General Meeting (AGM) for FY 2025-26, the ROC Delhi has considered and approved ....
Company Update / General View filing →
RSS feed for Dr Lalchandani Labs Ltd · the 50 most recent filings